4 Results for "

Barbituric acid

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Barbituric acid" in MCE Product Catalog:

Cat. No.: HY-121595
CAS No.: 21914-07-8
Synonyms: DPB
Target:  

Others

Research Areas:  

Neurological Disease

5,5-Diphenylbarbituric acid is an organic compound belonging to the derivatives of barbituric acid. 5,5-Diphenylbarbituric acid can be used for seizure study .
loading...
    loading...
Cat. No.: HY-A0232
CAS No.: 509-86-4
Synonyms: Medomin
Target:  

Drug Derivative

Research Areas:  

Neurological Disease

Heptabarbital (Medomin) is an oral activity Barbituric acid derivative. Heptabarbital has the potential for the research of insomnia .
loading...
    loading...
Cat. No.: HY-149003
CAS No.: 2494001-21-5
Target:  

PARP Apoptosis

Research Areas:  

Cancer

PARP1-IN-10 (compound 12c) is a no-cytotoxicity and potent PARP1 inhibitor with an IC50 value of 50.62 nM in vitro. PARP1-IN-10 causes cell cycle arrest at G2/M phase and apoptosis, and enhances the cytotoxicity of temozolomide (TMZ) .
loading...
    loading...
Cat. No.: HY-119514
CAS No.: 423744-89-2
BC12 is a barbituric acid derivative and a phosphodiesterase 7 (PDE7) inhibitor, with an IC50 of 0.77 μM against human targets. BC12 inhibits the enzymatic activity of PDE7, but this activity is not the driver of its immunomodulatory effects on T lymphocytes. BC12 blocks the upregulation of IL-2 transcription in activated T cells. BC12 modulates the transcriptional response of T cells upon stimulation, exerting anti-inflammatory and pro-stress effects. BC12 inhibits the proliferation of primary mouse T cells and the IL-2 secretion of human peripheral blood T lymphocytes. BC12 exerts immunosuppressive and immunomodulatory effects on T lymphocyte function. BC12 can be used in research related to T lymphocyte-mediated diseases .
loading...
    loading...